BGI Genomics’ 8-fold surge in stock price since its IPO has bumped up its founder’s net worth to above US$2 billion. Photo: Reuters

Chinese biotech firm BGI Genomics surges 8-fold since IPO, pushing founder’s networth above US$2 bln

China’s genetics testing market size is expected to more than triple to 42 billion yuan by 2021, according to a consultancy report

Topic |   Start-ups

TOP PICKS

BGI Genomics’ 8-fold surge in stock price since its IPO has bumped up its founder’s net worth to above US$2 billion. Photo: Reuters
READ FULL ARTICLE